Xinrui Ma

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Aqueous Solution

Positron Emission Tomography

Top Venues

European journal of nuclear medicine and molecular imaging

Chemical communications (Cambridge, England)

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Tao Zhang, Xinrui Ma, Muyun Xu, Jinghua Cai, Jianhua Cai, Yanguang Cao, Zhihao Zhang, Xin Ji, Jian He, German Oscar Fonseca Cabrera, Xuedan Wu, Weiling Zhao, Zhanhong Wu, Jin Xie, Zibo Li
Chelator boosted tumor-retention and pharmacokinetic properties: development of 64 Cu labeled radiopharmaceuticals targeting neurotensin receptor. European journal of nuclear medicine and molecular imaging 51 (11) (2024)
Tao Zhang, Xinrui Ma, Muyun Xu, Jinghua Cai, Jianhua Cai, Yanguang Cao, Zhihao Zhang, Xin Ji, Jian He, German Oscar Fonseca Cabrera, Xuedan Wu, Weiling Zhao, Zhanhong Wu, Jin Xie, Zibo Li
Chelator boosted tumor-retention and pharmacokinetic properties: development of 64 Cu labeled radiopharmaceuticals targeting neurotensin receptor. European journal of nuclear medicine and molecular imaging 51 (11) (2024)
Tao Zhang, Xinrui Ma, Muyun Xu, Jinghua Cai, Jianhua Cai, Yanguang Cao, Zhihao Zhang, Xin Ji, Jian He, German Oscar Fonseca Cabrera, Xuedan Wu, Weiling Zhao, Zhanhong Wu, Jin Xie, Zibo Li
Chelator boosted tumor-retention and pharmacokinetic properties: development of 64 Cu labeled radiopharmaceuticals targeting neurotensin receptor. European journal of nuclear medicine and molecular imaging (2024)
Muyun Xu, Xinrui Ma, Jessica E Pigga, He Zhang, Shuli Wang, Weiling Zhao, Huaifu Deng, Anna M Wu, Rihe Liu, Zhanhong Wu, Joseph M Fox, Zibo Li
Development of 18 F-Labeled hydrophilic trans -cyclooctene as a bioorthogonal tool for PET probe construction. Chemical communications (Cambridge, England) (2023)
Li Wang, Yubai Zhou, Xuedan Wu, Xinrui Ma, Bing Li, Ransheng Ding, Michael A Stashko, Zhanhong Wu, Xiaodong Wang, Zibo Li
The Synthesis and Initial Evaluation of MerTK Targeted PET Agents. Molecules (Basel, Switzerland) 27 (5) (2022)